An integral part of BioProspect's core business is its ability to combine scientific expertise with commercial awareness resulting in directing the company's objectives to further its research and development program towards innovative breakthrough technologies and products.

Board of Directors

Mr STEPHEN JOHN MORROW
Non-Executive Chairman
Mr. Morrow joined the Board on 18 June 2007. Mr. Morrow brings considerable agribusiness industry knowledge and contacts to the company and will provide the executive management and Board with an immediate level of expertise. He is a successful senior executive who is well regarded in the corporate sector with a reputation in directing challenging projects with favourable outcomes.
Mr. Morrow is a non-executive Director of the Gardener Smith Group and is Chairman of Brooklyn Park Olives. Most recently, he was CEO of Golden Circle Limited until 2006 and previously was General Manager Agribusiness with Suncorp Metway Bank and Managing Director of Primac Holdings.
Mr. Morrow is based in Brisbane.

Dr MICHAEL QUINLAN
Non-Executive Director
Dr Quinlan is a Consultant Physician and is a Clinical Professor of Medicine of the University of Western Australia. He is also Professor of Medicine and the Foundation Dean of the College of Health of the University of Notre Dame.
Dr Quinlan holds the position of Chairman of the St John of God Foundation. He is a former Chairman of the St John of God Healthcare National Governing Board and was an Inaugural Director of the Sisters of Charity Health Care National Council.
Dr. Quinlan is the Chairman of the companies Audit Committee.

Mr PETER LANDAU
Non-Executive Director
Mr. Landau was appointed to the Board on 29 May 2007. Mr. Landau is a corporate lawyer and corporate advisor having previously worked with Grange Consulting Group, Clayton Utz and as general counsel at Co-operative Bulk Handling. Mr. Landau is responsible for providing general corporate, capital raising, transaction and strategic advice to numerous ASX listed and unlisted companies.
Mr. Landau has project managed a significant number of mining exploration and development transactions including capital raisings, M & A, joint ventures and financings. Mr. Landau is a Director of a number of ASX listed companies with particular focus on mining, oil and gas exploration and development in Australia and Africa. Companies include NKWE Platinum Limited, Range Resources Limited and Cape Lambert Iron Ore Limited.

 
Mr PETER ADRIAN STEDWELL
Non-Executive Director

Mr. Stedwell was appointed to the Board on 1 September 2008. Mr Stedwell is an Executive Director of Solagran Limited and has over 35 years extensive corporate experience in Finance Director and Company secretarial roles. Peter is also a Director of Echo resources Limited. As Company Secretary of Solagran he is responsible for the preparation of financial statements and reports as well as lodgement of all statements with the ASX

Mr PETER CHARLES PELLEGRINO
Non-Executive Director

Mr. Pellegrino was appointed to the Board on 1 September 2008. Mr Pellegrino is also an Executive Director of Solagran Limited and is responsible for the establishment and implementation of the overseas production facilities for Solagran. Charles has operated in public practice for approximately 15 years as an accountant and financial advisor. He is the founder and Director of the Stanford Group of Companies. Charles holds a Batchelor of Arts and a Batchelor of Business in Accounting.

Mr ANTHONY LANGDON
Non-Executive Director

Mr. Langdon was appointed to the Board on 1 September 2008. Mr Langdon brings to the company significant experience in project and risk management within both the Government and private sectors. In the Government sector he has been responsible for the planning, co-ordination and completion of a number of multi-million dollar projects. Most recently, Mr Langdon completed strategic business assessments for various private sector interests in Africa and Australia. He has also been responsible for developing business continuity plans for a number of ASX listed and unlisted companies.

Executive Management

Mr PETER MAY
Chief Executive Officer

Mr. May was appointed as acting CEO on 23 September 2008 until his official appointment on November 3, as he completes prior commitments with his own agribusiness consultancy. Mr May's career has included stints with CFL, Incitec and Crop Care Australasia where he achieved overseas product registration and market development of a range of pest control products, including the suSCon controlled release formulation technology range of products.

In 2001, he founded his own consulting company Xavca Pty Ltd, where he has helped businesses evaluate new markets and commercialise products. Past clients have included leading agribusiness companies Syngenta, Sorex International, Babolna Bio and AgNova Technologies.

As an active member of the Australian Environmental Pest Managers Association (AEPMA), Mr May has established excellent contacts within the pest control industry in addition to the general agribusiness and animal health sectors. His educational qualifications include a Bachelor of Applied Science degree with first class honours from Queensland University and an MBA (majoring in international marketing) from the Queensland University of Technology.

Mr COLIN JOHNSTON
Chief Financial Officer and Company Secretary
Mr. Johnston is a CPA and holds a Diploma in Business Studies for Accountancy. He has 35 years experience with finance and management.
Mr. Johnston commenced his career as a trainee Accountant with Orica Pty Ltd (formerly ICI Australia Pty Ltd) in 1971. He had many various roles within Orica including Chief Financial Officer of ICI/Dulux PNG Pty Ltd, Pension Fund Accountant, Engineering Project Accountant and Chief Financial Officer of CropCare Australasia Pty Ltd. In 2000, he left Orica to be Chief Financial Officer and Company Secretary of Griffin Corporation Pty Ltd, a 49% subsidiary of DuPont. In September 2003, DuPont acquired the remaining shareholding of Griffin Corporation and closed their office in Milton, Queensland.
Mr. Johnston is responsible for managing the Company's capital management, fund raising needs and compliance with the Companies Act and ASX Listing Rules as well as internal and external reporting requirements He is also responsible for business development and the contractual arrangements surrounding such initiatives.

SCIENTIFIC EXPERTISE
An integral part of BioProspect's core business is its ability to combine scientific expertise with commercial awareness resulting in directing the company's objectives to further its research and development program towards innovative breakthrough technologies and products.
The company contracts its R&D work out to Australian and international institutions. Some of the Australian organisations are listed as:
  • The University of Western Sydney
  • Southern Cross University
  • Ensis Australia and New Zealand (a JV company with CSIRO)
  • Eureka AgResearch
  • DeGroot Technical Services